We are live on !
Find out more
C
Chescapmanager Portfolio holdings
AUM
$1.17B
Turnover
10.34%
1-Year Est. Return
42.44%
This Fund
S&P 500
This Quarter Est. Return
-8.51%
1 Year Est. Return
+42.44%
3 Year Est. Return
+202.08%
5 Year Est. Return
+174.76%
10 Year Est. Return
–
AUM
$706M
AUM Growth
-$205M
(-23%)
Cap. Flow
+$59.6M
Cap. Flow % of AUM
Cap. Flow %
8.44%
Top 10 Holdings %
Top 10 Hldgs %
42.37%
Holding
83
New
11
Increased
11
Reduced
14
Closed
19
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
1.1
years
Top 20 Avg Time Held
Equity + Options
1.3
years
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$28M |
| 2 |
Ginkgo Bioworks
DNA
|
+$24.3M |
| 3 |
Cazoo Group Ltd
CZOO
|
+$18.7M |
| 4 |
SPX FLOW, Inc.
FLOW
|
+$12.9M |
| 5 |
Blue Owl Capital
OWL
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Metals & Mining ETF
XME
|
+$14.9M |
| 2 |
Aecom
ACM
|
+$11M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.89M |
| 4 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$6.83M |
| 5 |
Martin Marietta Materials
MLM
|
+$4.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.65% |
| 2 | Healthcare | 21.11% |
| 3 | Industrials | 14.19% |
| 4 | Miscellaneous | 10.69% |
| 5 | Technology | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Cronos Group
CRON
$1.22B
| $47.1M | 6.68% |
8,327,090
| – | – |
2018 Q1
14 quarters
|
|
2
WillScot Mobile Mini Holdings
WSC
$3.32B
| $42M | 5.94% |
1,322,940
| – | – |
2017 Q3
16 quarters
|
|
3
Amazon
AMZN
$2.6T
| $36.1M | 5.12% |
220,000
| – | – |
2016 Q4
19 quarters
|
|
4
Alphabet (Google) Class A
GOOGL
$3.44T
| $33.4M | 4.73% |
250,000
| – | – |
2020 Q3
4 quarters
|
|
|
5
Coupang
CPNG
$25.8B
| $27.5M | 3.9% |
988,814
+810,888
| +456% | +$28M |
2021 Q1
2 quarters
|
|
6
Vertiv
VRT
$89.5B
| $27.2M | 3.85% |
1,129,200
-35,000
| -3% | -$930K |
2020 Q1
6 quarters
|
|
|
7
Ginkgo Bioworks
DNA
$755M
| $23.2M | 3.28% |
+50,000
| New | +$24.3M |
2021 Q3
0 quarters
|
|
|
8
DELISTED
Cazoo Group Ltd
CZOO
| $22.3M | 3.15% |
1,625
+1,000
| +160% | +$18.7M |
2020 Q4
3 quarters
|
|
9
Tvardi Therapeutics
TVRD
$10.6M
| $20.2M | 2.86% |
36,247
+8
| +0% | +$4.01K |
2016 Q4
19 quarters
|
|
10
PENN Entertainment
PENN
$2.13B
| $20.1M | 2.85% |
277,970
+38,043
| +16% | +$2.8M |
2017 Q4
15 quarters
|
|
11
DELISTED
Danimer Scientific, Inc.
DNMR
| $20.1M | 2.85% |
30,805
| – | – |
2020 Q4
3 quarters
|
|
12
Microsoft
MSFT
$3.88T
| $20M | 2.83% |
70,892
| – | – |
2020 Q2
5 quarters
|
|
13
US Foods
USFD
$22.4B
| $19.2M | 2.71% |
552,625
| – | – |
2020 Q2
5 quarters
|
|
|
14
Bristol-Myers Squibb
BMY
$128B
| $18.4M | 2.61% |
310,852
-135,000
| -30% | -$8.89M |
2019 Q4
7 quarters
|
|
|
IS
15
DELISTED
ironSource Ltd.
IS
| $17.8M | 2.52% |
1,638,727
+240,000
| +17% | +$2.38M |
2021 Q2
1 quarter
|
|
|
16
CALL
US Foods
USFD
$22.4B
| $17.3M | 2.45% |
500,000
| – | – |
2020 Q4
3 quarters
|
|
17
Cigna
CI
$78.8B
| $17M | 2.41% |
84,833
+25,000
| +42% | +$5.44M |
2018 Q1
14 quarters
|
|
18
Caesars Entertainment
CZR
$5.93B
| $15.6M | 2.21% |
138,983
+30,000
| +28% | +$2.93M |
2019 Q2
9 quarters
|
|
19
DELISTED
Theravance Biopharma
TBPH
| $14M | 1.98% |
1,892,452
+630,734
| +50% | +$7.05M |
2016 Q4
19 quarters
|
|
20
Cedar Fair
FUN
$765M
| $13.9M | 1.97% |
299,554
+22,990
| +8% | +$1.01M |
2021 Q2
1 quarter
|
|
21
Flex
FLEX
$32B
| $13.6M | 1.93% |
1,023,024
| – | – |
2020 Q4
3 quarters
|
|
22
Wynn Resorts
WYNN
$7.69B
| $13.6M | 1.93% |
160,498
+80,000
| +99% | +$7.9M |
2020 Q2
5 quarters
|
|
23
CALL
General Motors
GM
$74.2B
| $13.2M | 1.87% |
250,000
-250,000
| -50% | -$13.3M |
2021 Q1
2 quarters
|
|
24
DELISTED
Luminar Technologies
LAZR
| $13.1M | 1.86% |
55,986
| – | – |
2020 Q3
4 quarters
|
|
|
PAE
25
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $12.5M | 1.77% |
2,085,245
| – | – |
2020 Q1
6 quarters
|
|
Similar funds
CF
MI
M
Chescapmanager's Q3 2021 Portfolio in Review
As of Q3 2021, Chescapmanager held 83 positions worth $706M, down 23% from $911M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Chescapmanager deployed $59.6M of net new capital in Q3 2021, opening 11 new positions and adding to 11 existing holdings. Its largest new stake was Ginkgo Bioworks: 50,000 shares worth $23.2M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Aecom, an estimated $11M trimmed.
- Chescapmanager's largest Q3 2021 buy was Ginkgo Bioworks: 50,000 shares worth $23.2M.
- Chescapmanager added most to Coupang in Q3 2021, an estimated $28M increase.
- Chescapmanager's biggest Q3 2021 reduction was Aecom, cutting an estimated $11M.
- Chescapmanager fully exited State Street SPDR S&P Metals & Mining ETF in Q3 2021, selling an estimated $14.9M.
- Chescapmanager's ten largest holdings make up 42% of its $706M portfolio in Q3 2021.
- Chescapmanager opened 11 new positions and closed 19 in Q3 2021.
- Chescapmanager's portfolio value fell 23% quarter-over-quarter to $706M.
Based on Chescapmanager's 13F filing for Q3 2021, filed 15 Nov 2021.